In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis.
Mahdi AbastabarAli JediJacques GuillotMacit IlkitSamaneh EidiMohammad Taghi HedayatiTahereh ShokohiRoshanak Daie GhazviniAli Rezaei-MatehkolaeiFarzad KatiraeeJavad JavidniaBahram AhmadiHamid BadaliPublished in: Mycoses (2019)
FDA-approved antifungal drugs, that is luliconazole, efinaconazole and lanoconazole, showed the highest antifungal activity and should be promising candidates for the treatment of dermatophytosis caused by M canis. However, their therapeutic effectiveness remains to be determined in clinical settings.